Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals
申请人:SANDOZ AG
公开号:EP0221025A1
公开(公告)日:1987-05-06
Compounds of formula
wherein
Ra is a group -X-Z. Rb is R2, Rc is R3, Rd is R4 and Y is a group
Ra is R1, Rb is a group -X-Z, Rc is R2, Rd is R3 and Y is O, S or a group
R1, R2, R3, and R4 independently are C1-6alkyl not containing an asymmetric carbon atom. C3-7cycloalkyl or a ring
or in the case of R3 and R4 additionally hydrogen, or for R3 when Y is 0 or S
whereby R17 is hydrogen or C1-3alkyl and R18 and R19 are independently hydrogen C1-3alkyl or phenyl; each R5 is independently hydrogen. C1-3alkyl, n-butyl, i-butyl. t-butyl, C1-3alkoxy, n-butoxy, i-butoxy. trifluoromethyl, fluoro, chloro. bromo, phenyl, phenoxy or benzyloxy; each R6 is independently hydrogen. C1-3alkyl, C1-3alkoxy, trifluoromethyl. fluoro, chloro, bromo. phenoxy or benzyloxy, and each R7 is independently hydrogen, C1-2alkyl, C1-2alkoxy, fluoro or chloro. with the proviso that there may only be one each of trifluoromethyl, phenoxy or benzyloxy in each ring A present X is (CH2)m or (CH2)qCH =CH-(CH2)q, m is 0.1. 2 or 3 and both q's are 0 or one is 0 and the other is 1.
wherein Rg is hydrogen or C1-3alkyl,
in free acid form. or in the form of an ester or δ-lactone thereof or in salt form as appropriate, which compounds are indicated for use as pharmaceuticals in particular as hypolipoproteinemic and anti-atherosclerotic agents.
式中的化合物
式中
Ra 是基团 -X-ZRb 是 R2,Rc 是 R3,Rd 是 R4,Y 是基团
Ra 是 R1,Rb 是基团 -X-Z,Rc 是 R2,Rd 是 R3,Y 是 O、S 或基团
R1、R2、R3 和 R4 分别是不含不对称碳原子的 C1-6 烷基。C3-7 环烷基或一个环
或 R3 和 R4 另外为氢,或对于 R3 而言,当 Y 为 0 或 S 时
其中 R17 为氢或 C1-3 烷基,R18 和 R19 独立地为氢 C1-3 烷基或苯基;每个 R5 独立地为氢。C1-3烷基、正丁基、异丁基、叔丁基、C1-3烷氧基、正丁氧基、异丁氧基、三氟甲基、氟、氯、溴、苯基、苯氧基或苄氧基;每个 R6 独立地为氢、C1-3烷基、正丁基、异丁基、叔丁基、C1-3烷氧基、正丁氧基、异丁氧基、三氟甲基、氟、氯、溴、苯基、苯氧基或苄氧基。每个 R6 独立地为氢、C1-3烷基、C1-3烷氧基、三氟甲基、氟、氯、溴、苯氧基或苄氧基,每个 R7 独立地为氢、C1-2烷基、C1-2烷氧基、氟或氯,但每个环 A 中只能有一个三氟甲基、苯氧基或苄氧基,存在的 X 为 (CH2)m 或 (CH2)qCH =CH-(CH2)q,m 为 0.1。2或3,两个q均为0或一个为0,另一个为1。
其中 Rg 为氢或 C1-3 烷基、
以游离酸形式,或以其酯或δ-内酯形式,或以适当的盐形式,这些化合物可用作药物,特别是降脂蛋白血症和抗动脉粥样硬化药物。